Demirci, U. Et Al. 2019. Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey. 42nd Annual San Antonio Breast Cancer Symposium , (San-Antonio, Northern Mariana Islands).

Demirci, U., GÖKMEN, E., Eralp, Y., Gunduz, S., SEZGİN GÖKSU, S., KORKMAZ, T., ... Kostek, O.(2019). Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey . 42nd Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands

Demirci, Umut Et Al. "Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey," 42nd Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 2019

Demirci, Umut Et Al. "Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey." 42nd Annual San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands, 2019

Demirci, U. Et Al. (2019) . "Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey." 42nd Annual San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands.

@conferencepaper{conferencepaper, author={Umut Demirci Et Al. }, title={Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey}, congress name={42nd Annual San Antonio Breast Cancer Symposium}, city={San-Antonio}, country={Northern Mariana Islands}, year={2019}}